Viewing Study NCT02205112


Ignite Creation Date: 2025-12-26 @ 11:07 AM
Ignite Modification Date: 2026-01-13 @ 10:48 PM
Study NCT ID: NCT02205112
Status: COMPLETED
Last Update Posted: 2021-10-25
First Post: 2014-07-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP
Sponsor: TaiGen Biotechnology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module